Relieve your joints with CBD-based products

CBD, or cannabidiol, is a compound derived from Cannabis Sativa and Cannabis Indica that has been recognised for its many benefits to physical and mental health. Indeed, researchers have discovered that CBD has anti-stress, anti-inflammatory (1 ) and relaxing properties, making it a popular ingredient in various products such as dietary supplements and massage oils. The Stilla laboratory has chosen to use CBD as the main ingredient in its product ranges. In this article, we’ll show you how to relieve your joints with Stilla’s CBD-based products.

CBD: legal cannabis

At the heart of many debates and research topics, CBD, or cannabidiol, is a substance that is attracting growing interest. Derived mainly from cannabis sativa and cannabis indica, it is characterised by its beneficial effects on health without causing the psychoactive effects generally associated with cannabis. So it’s with great curiosity that we take a look in this section at how CBD, a component of cannabis, has managed to gain a legal place on the market.

What is CBD?

CBD, along with THC, is one of the main terpene organic cannabinoid compounds found mainly in Cannabis Sativa and Cannabis Indica. Unlike THC, CBD has no psychoactive effects and contains a very low THC content. On 29 December 2022, the Conseil d’État annulled the order of 30 December 2021 banning the sale of cannabis flowers and leaves with a THC content of less than 0.3%, ruling that“CBD (cannabidiol) has no psychoactive effect and does not cause dependence, (it) cannot be considered a narcotic product.”

Research into the effectiveness of CBD against arthritis pain remains inconclusive. Some small-scale, short-term or survey-based studies suggest potential benefits of CBD for arthritis pain, but these results are not yet convincing. However, preclinical studies show promise in reducing inflammation and pain associated with arthritis, but further research is needed to understand the mechanisms of action of CBD in chronic pain management, particularly for osteoarthritis (4) (5).

Promising research into epilepsy

Since it was isolated by the American chemist Roger Adams in 1940, the CBD molecule has been the subject of numerous studies aimed at highlighting and confirming its health benefits. So far, the results seem conclusive, as CBD is used to combat certain forms of epilepsy. It is found in Epidyolex, a cannabidiol-based medicine sold in pharmacies, indicated for the adjuvant treatment of epileptic seizures associated with Lennox-Gastaut and Dravet syndromes, as well as for reducing the signs associated with Bourneville sclerosis.

Products with multiple benefits

CBD is more than just a substance derived from cannabis: it’s a veritable goldmine with multiple therapeutic virtues. In fact, over the years, it has carved out a place of choice in the development of numerous products with a wide range of benefits. Whether it’s for relieving stress, easing inflammation or promoting sleep, CBD has become the star ingredient in many products.

One study found that CBD use was associated with improvements in pain (83%), physical function (66%) and sleep quality (66%) in arthritis patients. In particular, there was a 44% reduction in pain after CBD use, and the majority of respondents reported a reduction or cessation of other medications, including anti-inflammatory drugs, acetaminophen and opioids (5).

AEP and joint pain

The endocannabinoid agent PEA (palmitoylethanolamide) may offer a glimmer of hope to joint pain sufferers. With its anti-inflammatory and analgesic properties, PEA plays a key role in reducing joint inflammation and pain. Several studies have examined the efficacy of PEA in the treatment of joint pain. Preliminary results are promising, suggesting that PEA can reduce inflammation and alleviate pain. This may offer valuable relief to people witharthritis orosteoarthritis.

Before starting AEP treatment, it is important to consult a healthcare professional. Depending on the severity of symptoms and individual needs, a suitable dosage will be recommended. It should also be noted that PEA is generally well tolerated, with few reportedside effects.

The different forms of CBD-based products

Other non-medical CBD-basedproducts have also emerged in recent years. They are available in various forms: balm, oil, gummies, dietary supplements, etc. and are prized for their many benefits: anti-stress, anti-inflammatory, sleep-inducing, etc.

CBD-based products from Stilla to relieve joints and muscles

The Stilla laboratory has understood the potential of this molecule with a thousand and one virtues and has made CBD its flagship ingredient. The company offers a range of CBD-based products, but the best known are those that relieve joints and muscles. Here is a presentation of these products:

CBD Heating Balm: This product works on joints, relaxation and muscle recovery. It helps to soothe and relieve pain quickly.
Chinese CBD Balm: This balm works on joints and muscles. Thanks to its high content of Cannabis Sativa L, it offers an effective response to the various aches and pains of everyday life.
Cryogel CBD: This product acts on joints, blows and trauma. It helps to soothe and relieve pain quickly.

How to use Stilla’s CBD-based products to relieve your joints?

To enjoy the benefits of Stilla’s CBD-based products, simply apply them directly to the painful area. They are formulated to be absorbed quickly and effectively, for rapid relief of your joint pain.

The benefits of Stilla CBD-based products

Let’s delve into the fascinating world of the Stilla laboratory, which uses CBD to create products with impressive benefits. More than just relieving joint pain, these products improve your quality of life. Let’s discover the benefits of Stilla’s CBD-based products.

Rapid pain relief

Thanks to their anti-inflammatory and analgesic properties, Stilla’s CBD products can help relieve joint pain quickly.

A better quality of life

By reducing pain and inflammation, these products can improve your mobility and quality of life.

CBD safety and interactions

The safety of cannabidiol (CBD) in the treatment of joint pain, particularly in the context of arthritis, is an important topic to address. To date, research has shown that CBD is generally well tolerated, with few major safety concerns when used in moderate doses. However, it is essential to note that CBD can potentially interact with certain medications commonly used by arthritis sufferers.

These include corticosteroids (such as prednisone), tofacitinib (Xeljanz), naproxen (Aleve), celecoxib (Celebrex), tramadol (Ultram), as well as certain antidepressants such as amitriptyline (Elavil), citalopram (Celexa), fluoxetine (Prozac), mirtazapine (Remeron), paroxetine (Paxil) and sertraline (Zoloft). In addition, medications for fibromyalgia, such as gabapentin (Neurontin) and pregabalin (Lyrica), can also interact with CBD. It is therefore crucial to consult a healthcare professional before trying CBD, especially if you are taking one of these medications (6).

As far as side effects are concerned, although the majority of CBD users do not report any major problems, some side effects have been reported. These side effects include, but are not limited to, dry mouth, drowsiness or sedation, changes in appetite, dry eyes, impaired concentration, dizziness, headaches and digestive problems. It should be noted that 41% of CBD users for arthritis pain reported at least one side effect, most of which were considered mild (5).

Awareness of these potential interactions and side effects is crucial to the safe and informed use of CBD. Each individual reacts differently to CBD, and what works for one person may not be suitable for another. This underlines the importance of a personalised, supervised approach by a healthcare professional when exploring CBD as a treatment option for arthritis-related joint pain.

Precautions to take when using CBD products

It’s important to remember that although CBD is generally well tolerated, it can interact with certain medicines and cause side effects in some people. It is therefore advisable to consult a health professional. In fact, the effectiveness of CBD for pain relief in the elderly has shown mixed results, highlighting the need for greater quality control and a better understanding of its use and safety (3).

Legality and availability of CBD products

In this section, we explore the current regulatory framework in France and the European Union, highlighting the laws and directives that govern the marketing and use of CBD products.

Legal framework in France

In France, non-medicinal cannabidiol (CBD) is authorised because it is not considered a narcotic or a psychotropic drug. However, certain cannabinoids such as hexahydrocannabinol (HHC) and its derivatives are classified as narcotics and are therefore banned. French legislation authorises the marketing of CBD with a THC content of 0.3% or less, but only when the molecule is present in derived form, such as in creams or food products. In addition, the sale of CBD flowers and leaves ‘in their raw state’ has also been authorised since the Conseil d’Etat overturned the order of 30 December 2021 which banned their sale. (7)

European regulations

At European Union level, CBD is now subject to different regulations depending on the nature of the products or their composition. In January 2019, CBD was included in the Novel Foods Catalogue, and authorisation must be obtained before it can be marketed in the EU. However, the process has been temporarily suspended, and some Member States have begun withdrawing products from the market, although others have still allowed them to be sold or have not applied the rules. None of the 19 applications made to the European Food Safety Authority (EFSA) to recognise CBD products as novel foods were concluded until November 2022. (8)(9)

Conclusion

In conclusion, although current research into the use of CBD in the treatment of arthritis and joint pain is showing promising results, there are still significant gaps in our full understanding of its efficacy and mechanisms of action. Preclinical studies and patient feedback suggest that CBD may play a beneficial role in reducing the pain and inflammation associated with arthritis. However, it is crucial to stress that these results must be interpreted with caution.

To date, solid clinical evidence supporting the efficacy of CBD in the treatment of arthritis remains limited. Existing studies, while encouraging, are often small-scale, short-term or survey-based. This raises the need for more rigorous, large-scale clinical trials to reliably assess the efficacy of CBD in the treatment of arthritic conditions. Such trials would help to define clear guidelines regarding the optimal dosage, methods of administration and patient populations that could most benefit from these treatments.

In addition, further research is imperative to elucidate the potential interactions of CBD with other drugs and to understand its safety profile in more detail, particularly in people suffering from various forms of arthritis.

Finally, given the growing popularity of CBD and its increased use by patients suffering from joint pain, it is of the utmost importance that future research is directed towards a more thorough and evidence-based understanding of its role in the management of arthritis. This would enable healthcare professionals to better guide their patients in the use of CBD, ensuring a therapeutic approach that is both safe and effective (2).

FAQ

1. Are Stilla CBD products safe to use?

Yes, Stilla CBD products are generally safe to use. However, you should consult a healthcare professional before using them. Especially if you are taking other medications.

2. Are Stilla CBD products legal?

Yes, because they contain a very low level of THC, the psychoactive compound in cannabis.

3. Where can I buy Stilla CBD products?

In natural health shops, some online pharmacies, or directly on their website.

References

https://pubmed.ncbi.nlm.nih.gov/35999581/
https://pubmed.ncbi.nlm.nih.gov/32636158/
https://pubmed.ncbi.nlm.nih.gov/34191653/
https://www.health.harvard.edu/blog/does-cbd-help-with-arthritis-pain-2020041019418
https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-022-00154-9
https://www.arthritis.org/health-wellness/healthy-living/managing-pain/pain-relief-solutions/cbd-for-arthritis-pain
https://www.economie.gouv.fr/cedef/CBD-cannabidiol-reglementation
https://www.emcdda.europa.eu/news/2023/cannabis-laws-europe-questions-and-answers-policymaking
https://www.europarl.europa.eu/doceo/document/